Skip to end of metadata
Go to start of metadata

You are viewing an old version of this content. View the current version.

Compare with Current View Version History

« Previous Version 75 Current »

Project Scope 

This project team will create a users guide or White Paper with recommendations for analyses and displays associated with Hepatotoxicity, with a focus on Phase 2-4 clinical trials and integrated submission documents.

Project LeadsEmail

Melvin Munsaka, AbbVie

melvin.munsaka@abbvie.com

Terry Walsh, Astellas

terry.walsh@astellas.com

Alex Pearce, PHUSE Project Assistant

alexandra@phuse.global

CURRENT STATUS Q2 2025

  • Complete validation and publication of Stage 1 R programs.​
  • Complete full draft white paper for Stage 2.

Objectives & Deliverables

Timelines 
White PaperQ4 2023

Finalise Stage 2 of draft White Paper


  • No labels